Zurex Pharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Zurex Pharma General Information

Description

Developer of an antimicrobial technology designed to reduce the risks associated with infections. The company engages in the development and commercialization of anti-microbial products to overcome the scientific and technical barriers to improved skin antisepsis, reduce prep time and the risk of forming catheter-related bloodstream infections (CRBSI), enabling doctors and medical professionals to keep patients safe from infections.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2113 Eagle Drive
  • Middleton, WI 53562
  • United States
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Medical Supplies
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 2113 Eagle Drive
  • Middleton, WI 53562
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zurex Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business 06-Aug-2025 Completed Out of Business
8. Later Stage VC 28-Dec-2023 Completed Generating Revenue
7. Later Stage VC (Series E) 15-Jun-2020 Completed Generating Revenue
6. Later Stage VC (Series D) 12-Jun-2018 Completed Generating Revenue
5. Later Stage VC (Series C) 11-Aug-2016 Completed Generating Revenue
4. Later Stage VC (Series B) 30-Jun-2014 Completed Generating Revenue
3. Early Stage VC (Series A) 22-May-2012 Completed Startup
2. Early Stage VC 02-Mar-2012 $1M $2.67M Completed Startup
1. Early Stage VC (Series A) 04-May-2011 $1.67M $1.67M Completed Startup
To view Zurex Pharma’s complete valuation and funding history, request access »

Zurex Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 5,464,640 $0.000100 $0.07 $0.94 $0.94 1x $0.94 12.08%
Series A 7,413,466 $0.000100 $0.07 $0.36 $0.36 1x $0.36 16.38%
To view Zurex Pharma’s complete cap table history, request access »

Zurex Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an antimicrobial technology designed to reduce the risks associated with infections. The company engages in
Other Devices and Supplies
Middleton, WI
11 As of 2024

Rome, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zurex Pharma Competitors (1)

One of Zurex Pharma’s competitors is Angelini Pharma, a Private Equity-Backed company based in Rome, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Angelini Pharma Private Equity-Backed Rome, Italy
You’re viewing 1 of 1 competitors. Get the full list »

Zurex Pharma Patents

Zurex Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018275134-A1 Low-alcohol and sterilizable antimicrobial compositions and use thereof Active 02-Jun-2017
AU-2018275134-B2 Low-alcohol and sterilizable antimicrobial compositions and use thereof Inactive 02-Jun-2017
CA-3065323-A1 Low-alcohol and sterilizable antimicrobial compositions and use thereof Pending 02-Jun-2017
EP-3629734-A1 Low-alcohol and sterilizable antimicrobial compositions and use thereof Inactive 02-Jun-2017
WO-2018223080-A1 Low-alcohol and sterilizable antimicrobial compositions and use thereof Inactive 02-Jun-2017 A01N31/02
To view Zurex Pharma’s complete patent history, request access »

Zurex Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zurex Pharma FAQs

  • When was Zurex Pharma founded?

    Zurex Pharma was founded in 2008.

  • Where is Zurex Pharma headquartered?

    Zurex Pharma is headquartered in Middleton, WI.

  • What is the size of Zurex Pharma?

    Zurex Pharma has 11 total employees.

  • What industry is Zurex Pharma in?

    Zurex Pharma’s primary industry is Other Devices and Supplies.

  • Is Zurex Pharma a private or public company?

    Zurex Pharma is a Private company.

  • What is Zurex Pharma’s current revenue?

    The current revenue for Zurex Pharma is .

  • How much funding has Zurex Pharma raised over time?

    Zurex Pharma has raised $40.5M.

  • Who are Zurex Pharma’s competitors?

    Angelini Pharma is a competitor of Zurex Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process